ChrysalyneDSchmultsMD
Dermatology • Jamaica Plain, MADermatologic Surgery
Assistant Professor of Dermatology, Brigham and Women's Hospital
Dr. Schmults is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1153 Centre St Ste 4349
Jamaica Plain, MA 02130Phone+1 617-983-4626Fax+1 215-349-8339
Education & Training
NYU Grossman School of MedicineResidency, Dermatology, 1999 - 2002
Stanford Health Care-Sponsored Stanford UniversityInternship, Internal Medicine, 1998 - 1999
Yale School of MedicineClass of 1998
Certifications & Licensure
MA State Medical License 2007 - 2026
PA State Medical License 2003 - 2008
NY State Medical License 1999 - 2004
NJ State Medical License 2002 - 2003- American Board of Dermatology Dermatology
Clinical Trials
- Efficacy and Safety of 0.25% Timolol Gel in Healing Surgical Open Wounds Start of enrollment: 2018 Aug 20
- Efficacy and Safety of a Nanofat-seeded Biological Scaffold in Healing Lower Limb Surgical Defects Start of enrollment: 2019 Jan 30
- Efficacy and Safety of 0.25% Timolol Gel in Enhancing Full Thickness Skin Grafts Healing and Cosmetic Outcomes Start of enrollment: 2019 Jan 02
Publications & Presentations
PubMed
- 564 citationsCutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012.Pritesh S. Karia, Jiali Han, Chrysalyne D. Schmults
Journal of the American Academy of Dermatology. 2013-06-01 - 838 citationsPD-1 blockade with cemiplimab in advanced cutaneous squamous-cell carcinomaMichael R. Migden, Danny Rischin, Chrysalyne D. Schmults, Alexander Guminski, Axel Hauschild
The New England Journal of Medicine. 2018-06-04 - 3 citationsNeoadjuvant-Intent Immunotherapy in Advanced, Resectable Cutaneous Squamous Cell Carcinoma.Emily Y Kim, Emily S Ruiz, Mia S DeSimone, Sophia Z Shalhout, Glenn J Hanna
JAMA Otolaryngology-- Head & Neck Surgery. 2024-05-01
Journal Articles
- Association of Nodal Metastasis and Mortality with Vermilion vs Cutaneous Lip Location in Cutaneous Squamous Cell Carcinoma of the LipPooyan Rohani, Chrysalyne D Schmults, David M Wang, George F Murphy, Stefan Kraft, JAMA
Lectures
- Respect the Dormant BeastAmerican Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/1/2019
- A multi-gene risk signature for improved identification of cutaneous squamous cell carcinoma (cSCC) patients with a high risk of recurrence.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Other
- Incomplete Data in Cutaneous Squamous Cell Carcinoma Staging System AnalysisChrysalyne Schmults, MD, JAMA
https://www.doximity.com/articles/cdcfe100-7459-4a77-b7e2-a445399e30c0
UpToDate, Wolters Kluwer Health - 2013-02-25
Press Mentions
New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every YearOctober 13th, 2021
Systemic Option for Squamous Cell CarcinomaJanuary 20th, 2020
Perineural Invasion Ups Mortality Risk in Squamous Cell Skin CAJune 2nd, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
